Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Manolo Beelke"'
Autor:
Carlo Lazzaro, Manolo Beelke
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 6, Iss 4, Pp 317-332 (2005)
The aim of the paper is to compare Italian healthcare-related costs and effectiveness of 90Y-ibritumomab tiuxetan (Zevalin®) vs. currently available II and III line therapies (chemotherapy; radiotherapy; stem cell transplant) for relapsing or refrac
Externí odkaz:
https://doaj.org/article/8864c7cfd0fc44b8894bbad16923ecf8
Autor:
Kurt Marhardt, Joost Smolders, Frederik Barkhof, Manolo Beelke, Luigi M E Grimaldi, Myriam Schluep, Raymond Hupperts, Joep Killestein, Trygve Holmøy, Reinhold Vieth
Publikováno v:
Neurology, 93(20), e1906-e1916. Lippincott Williams and Wilkins
Neurology, 93(20), E1906-E1916. LIPPINCOTT WILLIAMS & WILKINS
Hupperts, R, Smolders, J, Vieth, R, Holmøy, T, Marhardt, K, Schluep, M, Killestein, J, Barkhof, F, Beelke, M, Grimaldi, L M E & SOLAR Study Group 2019, ' Randomized trial of daily high-dose vitamin D3 in patients with RRMS receiving subcutaneous interferon β-1a ', Neurology, vol. 93, no. 20, pp. e1906-e1916 . https://doi.org/10.1212/WNL.0000000000008445
Neurology
Neurology, 93(20), E1906-E1916. LIPPINCOTT WILLIAMS & WILKINS
Hupperts, R, Smolders, J, Vieth, R, Holmøy, T, Marhardt, K, Schluep, M, Killestein, J, Barkhof, F, Beelke, M, Grimaldi, L M E & SOLAR Study Group 2019, ' Randomized trial of daily high-dose vitamin D3 in patients with RRMS receiving subcutaneous interferon β-1a ', Neurology, vol. 93, no. 20, pp. e1906-e1916 . https://doi.org/10.1212/WNL.0000000000008445
Neurology
OBJECTIVE: In the phase II, randomized, double-blind, placebo-controlled Supplementation of Vigantol Oil versus Placebo Add-on in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS) Receiving Rebif Treatment (SOLAR) study (NCT01285401), we as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9063d4c32d25ce334cdcf54e7709fe1c
https://cris.maastrichtuniversity.nl/en/publications/1806879e-3b94-4053-a781-52c1786c9b08
https://cris.maastrichtuniversity.nl/en/publications/1806879e-3b94-4053-a781-52c1786c9b08
Autor:
Frederik Barkhof, Raymond Hupperts, Lizette Ghazi-Visser, Ulrike Hostalek, Luigi M.E. Grimaldi, Reinhold Vieth, Joep Killestein, Joost Smolders, Trygve Holmøy, Manolo Beelke, Peter Rieckmann, Myriam Schluep
Publikováno v:
Journal of the Neurological Sciences, 311(1-2), 44-49. Elsevier
Smolders, J, Hupperts, R, Barkhof, F, Grimaldi, L M E, Holmoy, T, Killestein, J, Rieckmann, P, Schluep, M, Vieth, R, Hostalek, U, Ghazi-Visser, L & Beelke, M 2011, ' Efficacy of vitamin D(3) as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial ', Journal of the Neurological Sciences, vol. 311, no. 1-2, pp. 44-49 . https://doi.org/10.1016/j.jns.2011.04.013
Journal of the Neurological Sciences, 311(1-2), 44-49. Elsevier Science
Smolders, J, Hupperts, R, Barkhof, F, Grimaldi, L M E, Holmoy, T, Killestein, J, Rieckmann, P, Schluep, M, Vieth, R, Hostalek, U, Ghazi-Visser, L & Beelke, M 2011, ' Efficacy of vitamin D(3) as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial ', Journal of the Neurological Sciences, vol. 311, no. 1-2, pp. 44-49 . https://doi.org/10.1016/j.jns.2011.04.013
Journal of the Neurological Sciences, 311(1-2), 44-49. Elsevier Science
Recent studies have demonstrated the immunomodulatory properties of vitamin D, and vitamin D deficiency may be a risk factor for the development of MS. The risk of developing MS has, in fact, been associated with rising latitudes, past exposure to su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd792576ef5f2d89fb5b4e6a9399c1be
https://doi.org/10.1016/j.jns.2011.04.013
https://doi.org/10.1016/j.jns.2011.04.013
Autor:
Mauro D'Antonio, Marco Battaglini, Sergio E. Baranzini, Nicola De Stefano, Bruce A.C. Cree, Pierre Jacques Farmer, Emmanuel Monnet, Manolo Beelke, Maria Laura Stromillo, Anne Cromer, Lorenz Lehr, Lohith Madireddy, Stacy J. Caillier
Publikováno v:
Baranzini, SE; Madireddy, LR; Cromer, A; D'Antonio, M; Lehr, L; Beelke, M; et al.(2015). Prognostic biomarkers of IFNb therapy in multiple sclerosis patients. Multiple Sclerosis, 21(7), 894-904. doi: 10.1177/1352458514555786. UCSF: Retrieved from: http://www.escholarship.org/uc/item/4t3870fr
Multiple sclerosis (Houndmills, Basingstoke, England), vol 21, iss 7
Multiple sclerosis (Houndmills, Basingstoke, England), vol 21, iss 7
Background: Interferon beta (IFNb) reduces relapse frequency and disability progression in patients with multiple sclerosis (MS). Objectives: Early identification of prognostic biomarkers of IFNb-treated patients will allow more effective management
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::104eebedd94b0017398cb29c442e69de
http://www.escholarship.org/uc/item/4t3870fr
http://www.escholarship.org/uc/item/4t3870fr
Autor:
Manolo Beelke, Carlo Lazzaro
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 6, Iss 4, Pp 317-332 (2005)
Farmeconomia. Health economics and therapeutic pathways; Vol 6, No 4 (2005); 317-332
Farmeconomia. Health economics and therapeutic pathways; Vol 6, No 4 (2005); 317-332
The aim of the paper is to compare Italian healthcare-related costs and effectiveness of 90Y-ibritumomab tiuxetan (Zevalin®) vs. currently available II and III line therapies (chemotherapy; radiotherapy; stem cell transplant) for relapsing or refrac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb28a6edf31a67ebd4f8a47977f7f7cc
https://doi.org/10.7175/fe.v6i4.845
https://doi.org/10.7175/fe.v6i4.845
Autor:
Mario Giovanni Terzano, Liborio Parrino, Tsuyoshi Watanabe, Fabrizio De Carli, Franco Ferrillo, Manolo Beelke, Lino Nobili, Arianna Smerieri
Publikováno v:
Brain Research Bulletin. 63:399-405
A number of phasic events influence sleep quality and sleep macrostructure. The detection of arousals and the analysis of cyclic alternating patterns (CAP) support the evaluation of sleep fragmentation and instability. Sixteen polygraphic overnight r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::703a5a4642ddb3314e94c558871e07fd
https://doi.org/10.1016/j.brainresbull.2003.12.013
https://doi.org/10.1016/j.brainresbull.2003.12.013
Autor:
Manolo Beelke, Paola Canovaro, Maria Eloisa Cabano, Silvia Angeli, Carlo Gandolfo, Massimo Del Sette, Lino Nobili, Franco Ferrillo
Publikováno v:
Sleep Medicine. 4:219-223
Under particular conditions a patent foramen ovale (PFO) can potentially give rise to ischemic stroke by means of paradoxic embolization. In obstructive sleep apnea syndrome (OSAS) right to left shunting (RLSh) can occur through PFO during periods of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a04da431e28661eee02ccbf00b2e877b
https://doi.org/10.1016/s1389-9457(02)00256-3
https://doi.org/10.1016/s1389-9457(02)00256-3
Obstructive Sleep Apnea can be Provocative for Right-to-Left Shunting Through a Patent Foramen Ovale
Autor:
Fabrizio De Carli, Lino Nobili, Franco Ferrillo, Manolo Beelke, Silvia Angeli, Massimo Del Sette, Paola Canovaro
Publikováno v:
Sleep. 25:21-27
Study Objectives: Under particular conditions, a patent foramen ovale (PFO) can potentially give rise to ischemic stroke by means of paradoxical embolization, due to right-to-left shunt. Our study aimed to evaluate the presence of right-to-left shunt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::763e1b048d63f305e70564d27ff3e432
https://doi.org/10.1093/sleep/25.8.21
https://doi.org/10.1093/sleep/25.8.21
Autor:
Cristiano Violani, Manolo Beelke, Giovanni Costa, Franco Ferrillo, Sergio Garbarino, Fabio Lucidi, Walter G. Sannita
Publikováno v:
Neuropsychobiology. 45:50-56
Night or shift work is to a relevant extent unavoidable, suits a growing preference for flexibility and is predicted to spread. However, a significant percentage of shift workers report discomfort or health problems and they often (15–20% of cases)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64fe523acc88f62a3d55670095891da7
https://doi.org/10.1159/000048674
https://doi.org/10.1159/000048674
Autor:
Pietro Cortelli, Elio Lugaresi, Giuseppe Plazzi, Lino Nobili, Paolo Tinuper, Franco Ferrillo, Pasquale Montagna, Fabrizio De Carli, Pierluigi Gambetti, Patrizia Avoni, Stefano Vandi, Manolo Beelke
Publikováno v:
Clinical neurophysiology 112 (2001): 1888–1992.
info:cnr-pdr/source/autori:Ferrillo F, Plazzi G., Nobili L., Beelke M., De Carli F., Cortelli P., Tinuper P., Avoni P., Vandi S., Gambetti P., Lugaresi E., Montagna P./titolo:Absence of sleep EEG markers in fatal familial insomnia healthy carriers: a spectral analysis study/doi:/rivista:Clinical neurophysiology/anno:2001/pagina_da:1888/pagina_a:1992/intervallo_pagine:1888–1992/volume:112
info:cnr-pdr/source/autori:Ferrillo F, Plazzi G., Nobili L., Beelke M., De Carli F., Cortelli P., Tinuper P., Avoni P., Vandi S., Gambetti P., Lugaresi E., Montagna P./titolo:Absence of sleep EEG markers in fatal familial insomnia healthy carriers: a spectral analysis study/doi:/rivista:Clinical neurophysiology/anno:2001/pagina_da:1888/pagina_a:1992/intervallo_pagine:1888–1992/volume:112
Objectives : Fatal familial insomnia (FFI) is linked to a mutation at codon 178 (C178) of the prion protein gene (PRNP). FFI is pathologically characterized by selective atrophy of the anteroventral and mediodorsal thalamic nuclei and clinically by l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0942a7ea98112e28db89e2d97d152930
https://doi.org/10.1016/s1388-2457(01)00600-9
https://doi.org/10.1016/s1388-2457(01)00600-9